MEDIPOST Co., Ltd. (078160.KQ)

KRW 12000.0

(-11.37%)

Total Liabilities Summary of MEDIPOST Co., Ltd.

  • MEDIPOST Co., Ltd.'s latest annual total liabilities in 2023 was 135.73 Billion KRW , down -36.93% from previous year.
  • MEDIPOST Co., Ltd.'s latest quarterly total liabilities in 2024 Q2 was 132.88 Billion KRW , down -1.67% from previous quarter.
  • MEDIPOST Co., Ltd. reported annual total liabilities of 215.21 Billion KRW in 2022, up 135.81% from previous year.
  • MEDIPOST Co., Ltd. reported annual total liabilities of 91.26 Billion KRW in 2021, down -10.05% from previous year.
  • MEDIPOST Co., Ltd. reported quarterly total liabilities of 135.15 Billion KRW for 2024 Q1, down -0.43% from previous quarter.
  • MEDIPOST Co., Ltd. reported quarterly total liabilities of 218.57 Billion KRW for 2023 Q1, up 1.56% from previous quarter.

Annual Total Liabilities Chart of MEDIPOST Co., Ltd. (2023 - 2016)

Historical Annual Total Liabilities of MEDIPOST Co., Ltd. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 135.73 Billion KRW -36.93%
2022 215.21 Billion KRW 135.81%
2021 91.26 Billion KRW -10.05%
2020 101.46 Billion KRW 5.93%
2019 95.78 Billion KRW 124.24%
2018 42.71 Billion KRW 25.21%
2017 34.11 Billion KRW 13.23%
2016 30.12 Billion KRW 0.0%

Peer Total Liabilities Comparison of MEDIPOST Co., Ltd.

Name Total Liabilities Total Liabilities Difference
HLB Co., Ltd. 169.47 Billion KRW 19.909%
iNtRON Biotechnology, Inc. 1.88 Billion KRW -7118.568%
BINEX Co., Ltd. 75.68 Billion KRW -79.34%
Bioneer Corporation 80.61 Billion KRW -68.384%
Anterogen.Co.,Ltd. 19.98 Billion KRW -579.126%
CrystalGenomics, Inc. 97.82 Billion USD -38.757%
Helixmith Co., Ltd 73.55 Billion KRW -84.529%
Chabiotech Co.,Ltd. 1069.23 Billion KRW 87.305%
Medy-Tox Inc. 137.14 Billion KRW 1.025%
Peptron, Inc. 16.36 Billion KRW -729.223%
Amicogen, Inc. 248.12 Billion KRW 45.295%
Genexine, Inc. 79.68 Billion KRW -70.344%
HLB Therapeutics Co.,Ltd. 29.27 Billion KRW -363.64%
LegoChem Biosciences, Inc. 41.28 Billion KRW -228.809%
ALTEOGEN Inc. 108.25 Billion KRW -25.381%
PharmaResearch Co., Ltd. 73.08 Billion KRW -85.718%
SillaJen, Inc. 19.4 Billion KRW -599.632%
JETEMA, Co., Ltd. 179.09 Billion KRW 24.209%
OliX Pharmaceuticals,Inc 52.48 Billion KRW -158.597%
Genomictree Inc. 7.81 Billion KRW -1637.463%
MedPacto, Inc. 9.56 Billion KRW -1318.975%
D&D Pharmatech 23.98 Billion KRW -465.902%
EASY BIO,Inc. 105.86 Billion KRW -28.211%
GI Innovation, Inc. 9.63 Billion KRW -1308.597%